NMB04
NMB04 is a recombinant anti-Human CD257 (BAFF) (BLyS) antibody. NMB04 binds with specificity and high affinity to soluble and membrane-bound Blys, and blocks Blys binding to receptors TACI, BCMA, and BR-3. NMB04 can be used for the research of autoimmune diseases.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
Species Reactivity
Human
体外実験
NMB04 (1 h) binds to soluble human Blys with high affinity, as indicated by an EC50 of 0.023 nM[1].
NMB04 binds to soluble human Blys with a high sub-nanomolar affinity (KD = 7.38×10-10 M)[1].
NMB04 (1 h) binds to membrane-bound human Blys expressed on 293C18 cells with an EC50 of 0.13 nM[1].
NMB04 (1 h) potently inhibits Blys binding to human BR3, TACI, and BCMA receptors with IC50 values of 0.12 nM, 0.25 nM, and 0.12 nM respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | AUC0-∞ | T1/2 |
|---|---|---|---|---|
| Cynomolgus Monkey[1] | 5 mg/kg | i.v. | 17456 μg·h/mL | 153.83 h |
体内実験
NMB04 (5 mg/kg; i.v.; once weekly; 4 weeks) inhibits CD20+ B cells in mesenteric lymph nodes and mature CD21+ B cells in peripheral blood in cynomolgus monkeys[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/C mice (female)[1]
-
Dosage:5 mg/kg
-
Administration:i.v.; on days 1 and 3
-
Result:Completely attenuated the increase in B220+/ThB+ mature splenic B cell population induced by human Blys.
Reduced the proportion of B220+/ThB+ cells to levels comparable to control group.
-
Animal Model:Cynomolgus Monkeys (2-4 years old, male)[1]
-
Dosage:5 mg/kg
-
Administration:i.v.; once weekly; 4 weeks
-
Result:Reduced the CD20+ B cell population in mesenteric lymph nodes to 18.31%.
Significantly inhibited the proliferation of mature CD21+ B cells in peripheral blood.
遺伝子ID
アクセッション番号
Target
TNFSF13B/BAFF/CD257
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
NMB04 関連分類
HY-P992424 関連分類
Powered by Bioz